DOI
https://doi.org/10.18849/ve.v1i1.17Abstract
Clinical bottom line
At normal clinical doses, there is no evidence that robenacoxib would provide superior patient comfort compared to meloxicam.
References
Schmid, V.B. et al. (2009) Analgesic and anti-inflammatory actions of robenacoxib in acute joint inflammation in dog. Journal of Veterinary Pharmacology and Therapeutics, 33 (2), pp. 118-131. http://dx.doi.org/10.1111/j.1365-2885.2009.01117.x
License
Copyright (c) 2016 Adam Swallow
This work is licensed under a Creative Commons Attribution 4.0 International License.
Veterinary Evidence uses the Creative Commons copyright Creative Commons Attribution 4.0 International License. That means users are free to copy and redistribute the material in any medium or format. Remix, transform, and build upon the material for any purpose, even commercially - with the appropriate citation.
Most read articles by the same author(s)
- Adam Swallow, In Bitches Diagnosed with Pyometra, is Medical Therapy Using Antibiosis Alone as Effective as Combining Ovariohysterectomy with Antibiosis in Reducing Morbidity and Mortality? , Veterinary Evidence: Vol. 1 No. 1 (2016): The inaugural issue
- Adam Swallow, Which is More Effective in Altering the Intra-Gastric pH in Dogs, Omeprazole or Ranitidine? , Veterinary Evidence: Vol. 1 No. 2 (2016): Our second issue
- Adam Swallow, Are Novel Allergen or Hydrolysed Diets an Effective Means of Reducing the Gastro-intestinal Signs in Dogs With Inflammatory Bowel Disease When Compared to Oral Prednisolone? , Veterinary Evidence: Vol. 2 No. 1 (2017): The first issue of 2017
- Adam Swallow, Investigating the Use of Gastroprotectants as a Means of Preventing Iatrogenic Gastrointestinal Signs Associated With Immunosuppressive Corticosteroid Therapy. A Retrospective Study , Veterinary Evidence: Vol. 2 No. 3 (2017): The third issue of 2017
